India Considers Grants To Private Firms That Find Disease Cures
This article was originally published in PharmAsia News
Executive Summary
India is considering creation of an $11 million grant program for drug makers in private industry that develop drugs for major tropical diseases such as tuberculosis. The grant system for private sector companies would be in addition to grants for public-funded research industries and soft loans already allowed to private companies. The Cabinet Committee on Economic Affairs has received a proposal from the Department of Science and Technology, which runs the grant program for public institutions. Targeted diseases include malaria and leprosy in addition to TB. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.